1. Home
  2. SVM vs CGEM Comparison

SVM vs CGEM Comparison

Compare SVM & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVM

Silvercorp Metals Inc.

N/A

Current Price

$8.68

Market Cap

1.4B

ML Signal

N/A

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$9.57

Market Cap

671.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SVM
CGEM
Founded
N/A
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
671.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SVM
CGEM
Price
$8.68
$9.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$9.00
$28.00
AVG Volume (30 Days)
5.3M
1.5M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
0.29%
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$323,391,000.00
N/A
Revenue This Year
$22.28
N/A
Revenue Next Year
$32.53
N/A
P/E Ratio
$74.39
N/A
Revenue Growth
33.99
N/A
52 Week Low
$2.87
$5.68
52 Week High
$8.87
$13.33

Technical Indicators

Market Signals
Indicator
SVM
CGEM
Relative Strength Index (RSI) 70.19 44.82
Support Level $8.04 $10.01
Resistance Level $8.87 $13.10
Average True Range (ATR) 0.43 1.00
MACD 0.07 -0.27
Stochastic Oscillator 87.67 3.73

Price Performance

Historical Comparison
SVM
CGEM

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: